NCT02081573

Brief Summary

Primary aim: examine feasibility and acceptability of a brief cognitive therapy protocol for type II diabetes administered by nurse care managers or health coaches via phone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 3, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 7, 2014

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

March 13, 2018

Completed
Last Updated

March 13, 2018

Status Verified

March 1, 2018

Enrollment Period

2.5 years

First QC Date

March 3, 2014

Results QC Date

September 27, 2016

Last Update Submit

March 9, 2018

Conditions

Keywords

Brief CBTsmartphone appmHealthdiabetes distressadherencecognitive behavioral therapy

Outcome Measures

Primary Outcomes (1)

  • Acceptability Questionnaire.

    The acceptability questionnaire measures feasibility and acceptability of the Brief CBT protocol. Adapted from Lewis JR.: IBM Computer Usability Satisfaction Questionnaires: Psychometric Evaluation and Instructions for Use. International Journal of Human-Computer Interaction 1995; 7 (1):67-78. Scale is scored as a mean and ranges from 1-7. In this adaptation, lower scores are better satisfaction.

    12 weeks

Secondary Outcomes (5)

  • Morisky Questionnaire

    12 weeks

  • Diabetes Distress Scale

    12 weeks

  • Medication Beliefs Scale

    12 weeks

  • HbA1c Level

    12 weeks

  • Body Mass Index

    12 weeks

Study Arms (1)

Brief CBT

EXPERIMENTAL

During the course of the twice/month diabetes management phone sessions the nurse care manager will work collaboratively with the patient to identify a dysfunctional belief that may be affecting adherence and could be improved by a brief CBT intervention (5-7 minutes). The care manager will utilize the CBT phone app to identify a CBT intervention that will be most appropriate for the situation. Each intervention is described step by step in the app. The nurse will go through the intervention and when completed will assure the patient's understanding.CBT interventions are geared towards helping the patient identify and restructure thinking that is impairing successful self-management of a chronic disease

Behavioral: Brief CBT

Interventions

Brief CBTBEHAVIORAL

During the course of the twice/month diabetes management phone sessions the nurse care manager will work collaboratively with the patient to identify a dysfunctional belief that may be affecting adherence and could be improved by a brief CBT intervention (5-7 minutes). The care manager will utilize the CBT phone app to identify a CBT intervention that will be most appropriate for the situation. Each intervention is described step by step in the app. The nurse will go through the intervention and when completed will assure the patient's understanding.CBT interventions are geared towards helping the patient identify and restructure thinking that is impairing successful self-management of a chronic disease

Also known as: CBT MobileWork
Brief CBT

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have a diagnosis of T2DM;
  • have a score of \>3 on the Diabetes Distress Scale;
  • be taking at least one oral antihyperglycemic agent (the patient may also be using injectable antihyperglycemic medications, including insulin);
  • have an HbA1c level of greater than 8 at baseline;
  • be receiving treatment for T2DM in the primary care setting;
  • be aged 30 - 65 years and
  • be able to read at the 8th-grade level and to provide informed consent.
  • Four nurse care managers will also be recruited from UPMC Health Care. To be considered they must be employed at UPMC Health Care and
  • Have received the Brief CBT Training that was given in Phase I of this study;
  • Be identified as a RN or a RN who is a diabetes nurse educator; and have Nurse Care Management responsibilities with patients who have Type 2 Diabetes.
  • Nurses will be excluded from the study if:
  • They did not successfully complete the training in Phase I or
  • Are not Nurse Care Managers at UPMC Health Care. -

You may not qualify if:

  • major psychiatric disorder and suicidal risk;
  • dementia or disorders with substantial cognitive impairment. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh School of Nursing

Pittsburgh, Pennsylvania, 15261, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Limitations and Caveats

This is a pilot feasibility study with small sample (N=10)

Results Point of Contact

Title
Judith A. Callan
Organization
University of Pittsburgh School of Nursing

Study Officials

  • Judith A. Callan, PhD, RN

    University of Pittsburgh School of Nursing

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

March 3, 2014

First Posted

March 7, 2014

Study Start

January 1, 2013

Primary Completion

July 1, 2015

Study Completion

July 1, 2016

Last Updated

March 13, 2018

Results First Posted

March 13, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

This is a small sample feasibility study.

Locations